Table I:
Type 2 Diabetes (DM2) Cohort Descriptive Statistics, 2008–2013 (N=7,081,113)
| Number bene-quarters (in millions) | Percent | |
|---|---|---|
| PATIENT CHARACTERISTICS | ||
| Age Group | ||
| 65–74 | 3.37 | 47.6 |
| 75–84 | 2.73 | 38.6 |
| 85+ | 0.97 | 13.8 |
| Sex | ||
| Male | 2.90 | 41.0 |
| Female | 4.18 | 59.0 |
| Non-white race/ethnicity | 1.81 | 25.5 |
| Black | 0.69 | 9.7 |
| Asian | 0.35 | 5.0 |
| Hispanic | 0.66 | 9.3 |
| Other non-Hispanic, non-white | 0.11 | 1.5 |
| Lives in socioeconomically disadvantaged zip code | 2.11 | 29.8 |
| Dually Eligible for Medicare & Medicaid | 2.46 | 34.8 |
| Lives in non-metropolitan county | 1.54 | 21.8 |
| Prescribed statins only | 6.60 | 93.2 |
| Prescribed statins & fibrates concurrently | 0.48 | 6.8 |
| Mean (Standard Deviation) | ||
| Charlson comorbidity score | 1.64 (2.00) | |
| PROVIDER CHARACTERISTICS | ||
| Provider age group | ||
| Under 65 | 5.85 | 82.7 |
| 65 or older | 1.23 | 17.3 |
| Provider sex | ||
| Male | 5.52 | 77.9 |
| Female | 1.56 | 22.1 |
| Provider Specialty | ||
| Primary Care | 5.62 | 79.3 |
| Cardiology | 0.35 | 5.0 |
| Endocrinology | 0.50 | 7.0 |
| All other specialties | 0.62 | 8.7 |
| FIBRATE USE | ||
| All years | 0.48 | 6.8 |
| 2008 | 0.04 | 6.4 |
| 2009 | 0.07 | 6.5 |
| 2010 | 0.08 | 6.9 |
| 2011 | 0.09 | 6.9 |
| 2012 | 0.10 | 6.8 |
| 2013 | 0.10 | 6.8 |